Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma
Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
In patients with peritoneal metastases of colorectal cancer could be a radical removal of all
tumor foci a significantly improved survival compared to a sole systemic chemotherapy are
additionally achieved by a hyperthermic intraoperative chemotherapy (HIPEC).